top of page
We invite you to view recent scientific poster presentation data. The posters are categorized by disease state. Click on the disease state below to view all posters in that category.
Search by
Poster
Number
1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
Alopecia Areata
Poster 3
Complete Scalp Hair Regrowth and Predictors of Response in Patients with Alopecia Areata Receiving Ritlecitinib 50 mg up to 3 Years in the ALLEGRO Clinical Trial Program Brett King, Rodney Sinclair, Lidia Rudnicka, Sergio Vañó-Galvan, Bianca Maria Piraccini, Manabu Ohyama, Wenyu Wu, Gianluca Bonfanti, Roger A Edwards, Robert Wolk, Stephen Goodrich, Dalia Wajsbrot, Helen Tran, Alexandre Lejeune < PREVIOUS POSTER NEXT POSTER > POSTER 3
Poster 4
Complete Hair Regrowth in Patients with Alopecia Areata (AA) and ≥25% Scalp Hair Loss Receiving Ritlecitinib up to 3 Years in ALLEGRO-LT Brett King, Rodney Sinclair, Lidia Rudnicka, Sergio Vañó-Galvan, Bianca Maria Piraccini, Manabu Ohyama, Wenyu Wu, Robert Wolk, Stephen Goodrich, Dalia Wajsbrot, Helen Tran, Alexandre Lejeune < PREVIOUS POSTER NEXT POSTER > POSTER 4
Poster 5
Long-Term Efficacy, Complete Scalp Hair Regrowth, and Normal Body Hair and Nails in Patients with Alopecia Areata (AA) Receiving Ritlecitinib 50 mg Once Daily up to 3 Years in the ALLEGRO Clinical Trial Program Brett King, Rodney Sinclair, Lidia Rudnicka, Sergio Vañó-Galvan, Bianca Maria Piraccini, Manabu Ohyama, Wenyu Wu, Robert Wolk, Dalia Wajsbrot, Helen Tran, Alexandre Lejeune < PREVIOUS POSTER NEXT POSTER > POSTER 5
Poster 6
Early Improvement in Scalp Hair Regrowth with Deuruxolitinib in Patients with Severe Alopecia Areata: Pooled Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Arash Mostaghimi, MD, MPH; Maryanne M. Senna, MD; Brett King, MD, PhD; Natasha A. Mesinkovska, MD, PhD; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 6
Poster 7
Efficacy of Deuruxolitinib Across Subgroups of Patients with Severe Alopecia Areata by Demographic and Baseline Characteristics: Pooled Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Maryanne M. Senna, MD; Brett King, MD, PhD; Natasha A. Mesinkovska, MD, PhD; Arash Mostaghimi, MD, MPH; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 7
Poster 8
Deuruxolitinib Improves Scalp Hair Regrowth Over Time in Patients with Severe Alopecia Areata: Pooled Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Natasha A. Mesinkovska, MD, PhD; Arash Mostaghimi, MD, MPH; Maryanne M. Senna, MD; Brett King, MD, PhD; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 8
Poster 9
Efficacy of Deuruxolitinib in Patients with Severe Alopecia Areata by Baseline Nail Involvement: Pooled Post Hoc Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Natasha A. Mesinkovska, MD, PhD; Brett King, MD, PhD, Arash Mostaghimi, MD, MPH; Maryanne M. Senna, MD; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 9
Poster 10
Efficacy of Deuruxolitinib in Patients with Severe Alopecia Areata by Baseline Eyelash Involvement: Pooled Post Hoc Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Maryanne M. Senna, MD; Natasha A. Mesinkovska, MD, PhD; Brett King, MD, PhD; Arash Mostaghimi, MD, MPH; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 10
Poster 11
Efficacy of Deuruxolitinib in Patients with Severe Alopecia Areata by Baseline Eyebrow Involvement: Pooled Post Hoc Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Arash Mostaghimi, MD, MPH; Maryanne M. Senna, MD; Natasha A. Mesinkovska, MD, PhD; Brett King, MD, PhD; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD < PREVIOUS POSTER NEXT POSTER > POSTER 11
Poster 12
Efficacy of Deuruxolitinib in Patients with Severe Alopecia Areata by Baseline Alopecia Areata Episode Duration: Pooled Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Authors: Brett King, Jennifer Soung, Christos Tziotzios, Lidia Rudnicka, Pascal Joly, Melinda Gooderham, Rodney Sinclair, Susan D. Anway, Dalia Wajsbrot, Alexandre Lejeune, Samuel H. Zwillich < PREVIOUS POSTER NEXT POSTER > POSTER 12
bottom of page